- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0064354

Neodivine Pharma Private Limited
About Neodivine Pharma Private Limited
Data last updated:
Neodivine Pharma Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 09 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24110UP2019PTC115712.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pushpa Tiwari and Khushboo Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 1105 11th Floor D Skytech Matrott Noida Sector 76, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.41 Lakh, a growth of 84% compared to the previous year. For the same year it recorded a net loss of ₹64,870 (net margin -26.9%) and EBITDA of -₹63,490 (EBITDA margin -26.3%). Revenue has grown at a compounded annual rate (CAGR) of 44% over three years.
Neodivine Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0064354).
Company details
Recognitions & Rankings of Neodivine Pharma
Contact details
Neodivine Pharma Private Limited's registered office is in Noida, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressD – 1105 11th Floor D Skytech Matrott Noida Sector 76, Uttar Pradesh, India – 201301
- IndustryChemicals, Manufacturing, Basic Chemical, Basic Chemicals Except Fertilizers And Nitrogen Compounds
To see the full contact details of Neodivine Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Neodivine Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Neodivine Pharma Private Limited, buy the company report.
Financials of Neodivine Pharma Private Limited
FY 2025 filings availableNeodivine Pharma Private Limited reported revenue of ₹2.41 Lakh (up 84% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 44% over three years, including 84% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹63,490 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹64,870 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -26.3% | ||||
| Net Profit Margin | -26.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neodivine Pharma Private Limited, buy the company report.
Board of directors of Neodivine Pharma Private Limited
Neodivine Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pushpa Tiwari | Director | 09 Apr 2019 | 7 Years 6 Months | Current |
| Khushboo Srivastava | Director | 09 Apr 2019 | 7 Years 6 Months | Current |
Peer comparison
Neodivine Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hegenlife Remedies Private Limited | ₹2.44 Lakh (FY 2024) | -43.0% | Thane, Maharashtra, India | |||
| Abiotex Global Private Limited | ₹2.44 Lakh (FY 2020) | -89.0% | Delhi, India | |||
| Jito&Karan Industries Private Limited | ₹2.43 Lakh (FY 2025) | -63.0% | Durgapur, West Bengal, India | |||
| Bezwingen Pharma Private Limited | ₹2.42 Lakh (FY 2024) | Eranhipalam, Kerala, India | ||||
| Sorrell Pharmaceuticals Private Limited | ₹2.42 Lakh (FY 2022) | 88.0% | Hyderabad, Telangana, India | |||
| Neodivine Pharma Private Limitedthis company | ₹2.41 Lakh (FY 2024) | -₹64,870 | -26.9% | 84.0% | Noida, Uttar Pradesh, India | |
| Sadashiv Metalics Private Limited | ₹2.4 Lakh (FY 2025) | 0.0% | Chandigarh, India | |||
| Curiyan Pharmaceutical Private Limited | ₹2.4 Lakh (FY 2024) | -64.0% | Boisar, Maharashtra, India | |||
| Vardhman Pharmaceuticals Private Limited | ₹2.39 Lakh (FY 2025) | -8.0% | Uttar Pradesh, India | |||
| Lifeherbs Laboratories Private Limited | ₹2.39 Lakh (FY 2024) | -24.0% | Jalaun, Uttar Pradesh, India | |||
| Rakmind Lifescience Private Limited | ₹2.38 Lakh (FY 2019) | 50.0% | Thane, Maharashtra, India |
To see the full peer comparison of Neodivine Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Neodivine Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neodivine Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Neodivine Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Neodivine Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Khushboo Srivastava was appointed as Director on 09 Apr 2019.
Frequently asked questions
Neodivine Pharma is an active private limited company based in Noida, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 09 April 2019 (7+ years old) and is registered under CIN U24110UP2019PTC115712.
Neodivine Pharma has 2 current directors:
- Pushpa Tiwari - Director
- Khushboo Srivastava - Director
The latest financial statements of Neodivine Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Neodivine Pharma is U24110UP2019PTC115712. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neodivine Pharma was incorporated on 09 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Neodivine Pharma by revenue are Hegenlife Remedies Private Limited, Abiotex Global Private Limited, Jito&Karan Industries Private Limited, Bezwingen Pharma Private Limited, Sorrell Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Khushboo Srivastava was appointed as Director on 09 Apr 2019. Pushpa Tiwari was appointed as Director on 09 Apr 2019.
Yes, Neodivine Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0064354).
The registered office of Neodivine Pharma is at D – 1105 11th Floor D Skytech Matrott Noida Sector 76, Uttar Pradesh, India – 201301.
Neodivine Pharma operates in the chemicals industry, in the manufacturing segment.
Neodivine Pharma can be reached at its registered office: D – 1105 11th Floor D Skytech Matrott Noida Sector 76, Uttar Pradesh, India – 201301.

